All the news articles and press releases in one place.

Date / Time Source Company Sector Market Cap Announcement
10Mar23 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03 RNS ANGLE plc Health £49.5m Angle PLC - Holding(s) in Company
09Feb23 14:44 RNS ANGLE plc Health £49.5m Angle PLC - Director/PDMR shareholding
19Jan23 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20 RNS ANGLE plc Health £49.5m Angle PLC - Holding(s) in Company
10Jan23 18:20 RNS ANGLE plc Health £49.5m Angle PLC - Holding(s) in Company
05Jan23 07:01 RNS ANGLE plc Health £49.5m Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Business Update
12Dec22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
02Nov22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
18Oct22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 RNS ANGLE plc Health £49.5m Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - First regional distribution agreement
30Sep22 17:30 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
30Sep22 17:30 RNS ANGLE plc Health £49.5m Angle PLC - Holding(s) in Company
29Sep22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Interim Results
28Sep22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 RNS ANGLE plc Health £49.5m Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33 RNS ANGLE plc Health £49.5m Angle PLC - Holding(s) in Company
20Jul22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 RNS ANGLE plc Health £49.5m Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Results of Capital Raise
14Jul22 17:24 RNS ANGLE plc Health £49.5m Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 RNS ANGLE plc Health £49.5m Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
29Jun22 16:35 RNS ANGLE plc Health £49.5m Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
22Jun22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Secured contract from pharma services customer
16Jun22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Partnership with major United States urology group
27May22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Molecular characterisation of CTCs
25May22 12:30 RNS ANGLE plc Health £49.5m Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Preliminary Results
20Apr22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Update on laboratory accreditation
02Mar22 18:29 RNS ANGLE plc Health £49.5m Angle PLC - Holding(s) in Company
18Feb22 17:13 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
21Jan22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
01Dec21 18:11 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
01Dec21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
17Nov21 10:32 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
15Nov21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
12Nov21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
02Nov21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Change of Adviser
21Oct21 17:25 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
15Oct21 17:45 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
30Sep21 16:02 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
30Sep21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Interim Results
27Sep21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Parsortix demonstrates ability to isolate CTCs
22Sep21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Study shows use of Parsortix to assess PD-L1
20Sep21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Parsortix enables gene expression analysis in mPCa
07Sep21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Notice of Interim Results and Webcast
24Aug21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Director/PDMR Shareholding
09Aug21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Study highlights superior performance of Parsortix
06Aug21 13:17 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
03Aug21 15:13 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
28Jul21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Contract secured for bespoke assay development
09Jul21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Harvesting CTCs from brain metastasis patients
07Jul21 18:34 RNS ANGLE plc Health £49.5m Angle PLC - Director/PDMR Shareholding
02Jul21 10:45 RNS ANGLE plc Health £49.5m Angle PLC - Issue of Equity
30Jun21 15:44 RNS ANGLE plc Health £49.5m Angle PLC - Result of AGM
25Jun21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Result of Accelerated Bookbuild
24Jun21 18:28 RNS ANGLE plc Health £49.5m Angle PLC - Accelerated bookbuild to raise up to £20m
18Jun21 11:42 RNS ANGLE plc Health £49.5m Angle PLC - Annual General Meeting update
18Jun21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - ctDNA and CTCs have differences in EGFR mutations
04Jun21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Update on submission for FDA clearance
01Jun21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Potential to prevent breast cancer relapse
20May21 07:00 RNS ANGLE plc Health £49.5m Angle PLC - Parsortix demonstrates oesophageal cancer utility
19May21 16:37 RNS ANGLE plc Health £49.5m Angle PLC - Exercise of options and total voting rights
11May21 07:00 RNS-R ANGLE plc Health £49.5m Parsortix study uncovers targets in TNBC patients
30Apr21 11:22 RNS ANGLE plc Health £49.5m Exercise of options and total voting rights
29Apr21 07:00 RNS ANGLE plc Health £49.5m Preliminary Results
26Apr21 07:00 RNS ANGLE plc Health £49.5m Ovarian cancer study patient enrolment completed
16Apr21 07:00 RNS ANGLE plc Health £49.5m First large-scale pharma services contract secured
15Apr21 16:10 RNS ANGLE plc Health £49.5m Notice of Preliminary Results and Webcast
12Apr21 07:00 RNS-R ANGLE plc Health £49.5m ANGLE's Parsortix system showcased at AACR 2021
30Mar21 07:00 RNS ANGLE plc Health £49.5m Global launch of clinical services laboratories
Date / Time Source Company % Chg
10Mar23 07:00 RNS ANGLE plc -5.70%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03 RNS ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
09Feb23 14:44 RNS ANGLE plc -5.70%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00 RNS ANGLE plc -5.70%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20 RNS ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
10Jan23 18:20 RNS ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
05Jan23 07:01 RNS ANGLE plc -5.70%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 RNS ANGLE plc -5.70%
Angle PLC - Business Update
12Dec22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
02Nov22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
18Oct22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 RNS ANGLE plc -5.70%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 RNS ANGLE plc -5.70%
Angle PLC - First regional distribution agreement
30Sep22 17:30 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Sep22 17:30 RNS ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
29Sep22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Interim Results
28Sep22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 RNS ANGLE plc -5.70%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 RNS ANGLE plc -5.70%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33 RNS ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
20Jul22 07:00 RNS ANGLE plc -5.70%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 RNS ANGLE plc -5.70%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Results of Capital Raise
14Jul22 17:24 RNS ANGLE plc -5.70%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 RNS ANGLE plc -5.70%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
29Jun22 16:35 RNS ANGLE plc -5.70%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
22Jun22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Partnership with major United States urology group
27May22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30 RNS ANGLE plc -5.70%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Preliminary Results
20Apr22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29 RNS ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
18Feb22 17:13 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
21Jan22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00 RNS ANGLE plc -5.70%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
01Dec21 18:11 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
01Dec21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
17Nov21 10:32 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
15Nov21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
12Nov21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
02Nov21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Change of Adviser
21Oct21 17:25 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
15Oct21 17:45 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Sep21 16:02 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Sep21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Interim Results
27Sep21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Parsortix demonstrates ability to isolate CTCs
22Sep21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Study shows use of Parsortix to assess PD-L1
20Sep21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Parsortix enables gene expression analysis in mPCa
07Sep21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Notice of Interim Results and Webcast
24Aug21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Director/PDMR Shareholding
09Aug21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Study highlights superior performance of Parsortix
06Aug21 13:17 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
03Aug21 15:13 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
28Jul21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Contract secured for bespoke assay development
09Jul21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Harvesting CTCs from brain metastasis patients
07Jul21 18:34 RNS ANGLE plc -5.70%
Angle PLC - Director/PDMR Shareholding
02Jul21 10:45 RNS ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Jun21 15:44 RNS ANGLE plc -5.70%
Angle PLC - Result of AGM
25Jun21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Result of Accelerated Bookbuild
24Jun21 18:28 RNS ANGLE plc -5.70%
Angle PLC - Accelerated bookbuild to raise up to £20m
18Jun21 11:42 RNS ANGLE plc -5.70%
Angle PLC - Annual General Meeting update
18Jun21 07:00 RNS ANGLE plc -5.70%
Angle PLC - ctDNA and CTCs have differences in EGFR mutations
04Jun21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Update on submission for FDA clearance
01Jun21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Potential to prevent breast cancer relapse
20May21 07:00 RNS ANGLE plc -5.70%
Angle PLC - Parsortix demonstrates oesophageal cancer utility
19May21 16:37 RNS ANGLE plc -5.70%
Angle PLC - Exercise of options and total voting rights
11May21 07:00 RNS-R ANGLE plc -5.70%
Parsortix study uncovers targets in TNBC patients
30Apr21 11:22 RNS ANGLE plc -5.70%
Exercise of options and total voting rights
29Apr21 07:00 RNS ANGLE plc -5.70%
Preliminary Results
26Apr21 07:00 RNS ANGLE plc -5.70%
Ovarian cancer study patient enrolment completed
16Apr21 07:00 RNS ANGLE plc -5.70%
First large-scale pharma services contract secured
15Apr21 16:10 RNS ANGLE plc -5.70%
Notice of Preliminary Results and Webcast
12Apr21 07:00 RNS-R ANGLE plc -5.70%
ANGLE's Parsortix system showcased at AACR 2021
30Mar21 07:00 RNS ANGLE plc -5.70%
Global launch of clinical services laboratories
Date / Time Company % Chg
10Mar23 07:00 ANGLE plc -5.70%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03 ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
09Feb23 14:44 ANGLE plc -5.70%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00 ANGLE plc -5.70%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20 ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
10Jan23 18:20 ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
05Jan23 07:01 ANGLE plc -5.70%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 ANGLE plc -5.70%
Angle PLC - Business Update
12Dec22 07:00 ANGLE plc -5.70%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 ANGLE plc -5.70%
Angle PLC - Issue of Equity
02Nov22 07:00 ANGLE plc -5.70%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 ANGLE plc -5.70%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 ANGLE plc -5.70%
Angle PLC - Issue of Equity
18Oct22 07:00 ANGLE plc -5.70%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 ANGLE plc -5.70%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 ANGLE plc -5.70%
Angle PLC - First regional distribution agreement
30Sep22 17:30 ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Sep22 17:30 ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
29Sep22 07:00 ANGLE plc -5.70%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 ANGLE plc -5.70%
Angle PLC - Interim Results
28Sep22 07:00 ANGLE plc -5.70%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 ANGLE plc -5.70%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 ANGLE plc -5.70%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 ANGLE plc -5.70%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 ANGLE plc -5.70%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33 ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
20Jul22 07:00 ANGLE plc -5.70%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 ANGLE plc -5.70%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 ANGLE plc -5.70%
Angle PLC - Results of Capital Raise
14Jul22 17:24 ANGLE plc -5.70%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 ANGLE plc -5.70%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 ANGLE plc -5.70%
Angle PLC - Issue of Equity
29Jun22 16:35 ANGLE plc -5.70%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 ANGLE plc -5.70%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 ANGLE plc -5.70%
Angle PLC - Issue of Equity
22Jun22 07:00 ANGLE plc -5.70%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00 ANGLE plc -5.70%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00 ANGLE plc -5.70%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00 ANGLE plc -5.70%
Angle PLC - Partnership with major United States urology group
27May22 07:00 ANGLE plc -5.70%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30 ANGLE plc -5.70%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00 ANGLE plc -5.70%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00 ANGLE plc -5.70%
Angle PLC - Preliminary Results
20Apr22 07:00 ANGLE plc -5.70%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00 ANGLE plc -5.70%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00 ANGLE plc -5.70%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00 ANGLE plc -5.70%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00 ANGLE plc -5.70%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00 ANGLE plc -5.70%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29 ANGLE plc -5.70%
Angle PLC - Holding(s) in Company
18Feb22 17:13 ANGLE plc -5.70%
Angle PLC - Issue of Equity
21Jan22 07:00 ANGLE plc -5.70%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00 ANGLE plc -5.70%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00 ANGLE plc -5.70%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00 ANGLE plc -5.70%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29 ANGLE plc -5.70%
Angle PLC - Issue of Equity
01Dec21 18:11 ANGLE plc -5.70%
Angle PLC - Issue of Equity
01Dec21 07:00 ANGLE plc -5.70%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33 ANGLE plc -5.70%
Angle PLC - Issue of Equity
17Nov21 10:32 ANGLE plc -5.70%
Angle PLC - Issue of Equity
15Nov21 07:00 ANGLE plc -5.70%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00 ANGLE plc -5.70%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51 ANGLE plc -5.70%
Angle PLC - Issue of Equity
12Nov21 07:00 ANGLE plc -5.70%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00 ANGLE plc -5.70%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40 ANGLE plc -5.70%
Angle PLC - Issue of Equity
02Nov21 07:00 ANGLE plc -5.70%
Angle PLC - Change of Adviser
21Oct21 17:25 ANGLE plc -5.70%
Angle PLC - Issue of Equity
15Oct21 17:45 ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Sep21 16:02 ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Sep21 07:00 ANGLE plc -5.70%
Angle PLC - Interim Results
27Sep21 07:00 ANGLE plc -5.70%
Angle PLC - Parsortix demonstrates ability to isolate CTCs
22Sep21 07:00 ANGLE plc -5.70%
Angle PLC - Study shows use of Parsortix to assess PD-L1
20Sep21 07:00 ANGLE plc -5.70%
Angle PLC - Parsortix enables gene expression analysis in mPCa
07Sep21 07:00 ANGLE plc -5.70%
Angle PLC - Notice of Interim Results and Webcast
24Aug21 07:00 ANGLE plc -5.70%
Angle PLC - Director/PDMR Shareholding
09Aug21 07:00 ANGLE plc -5.70%
Angle PLC - Study highlights superior performance of Parsortix
06Aug21 13:17 ANGLE plc -5.70%
Angle PLC - Issue of Equity
03Aug21 15:13 ANGLE plc -5.70%
Angle PLC - Issue of Equity
28Jul21 07:00 ANGLE plc -5.70%
Angle PLC - Contract secured for bespoke assay development
09Jul21 07:00 ANGLE plc -5.70%
Angle PLC - Harvesting CTCs from brain metastasis patients
07Jul21 18:34 ANGLE plc -5.70%
Angle PLC - Director/PDMR Shareholding
02Jul21 10:45 ANGLE plc -5.70%
Angle PLC - Issue of Equity
30Jun21 15:44 ANGLE plc -5.70%
Angle PLC - Result of AGM
25Jun21 07:00 ANGLE plc -5.70%
Angle PLC - Result of Accelerated Bookbuild
24Jun21 18:28 ANGLE plc -5.70%
Angle PLC - Accelerated bookbuild to raise up to £20m
18Jun21 11:42 ANGLE plc -5.70%
Angle PLC - Annual General Meeting update
18Jun21 07:00 ANGLE plc -5.70%
Angle PLC - ctDNA and CTCs have differences in EGFR mutations
04Jun21 07:00 ANGLE plc -5.70%
Angle PLC - Update on submission for FDA clearance
01Jun21 07:00 ANGLE plc -5.70%
Angle PLC - Potential to prevent breast cancer relapse
20May21 07:00 ANGLE plc -5.70%
Angle PLC - Parsortix demonstrates oesophageal cancer utility
19May21 16:37 ANGLE plc -5.70%
Angle PLC - Exercise of options and total voting rights
11May21 07:00 ANGLE plc -5.70%
Parsortix study uncovers targets in TNBC patients
30Apr21 11:22 ANGLE plc -5.70%
Exercise of options and total voting rights
29Apr21 07:00 ANGLE plc -5.70%
Preliminary Results
26Apr21 07:00 ANGLE plc -5.70%
Ovarian cancer study patient enrolment completed
16Apr21 07:00 ANGLE plc -5.70%
First large-scale pharma services contract secured
15Apr21 16:10 ANGLE plc -5.70%
Notice of Preliminary Results and Webcast
12Apr21 07:00 ANGLE plc -5.70%
ANGLE's Parsortix system showcased at AACR 2021
30Mar21 07:00 ANGLE plc -5.70%
Global launch of clinical services laboratories